BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Dec. 03, 2022	Dec. 04, 2021	Dec. 03, 2022	Dec. 04, 2021
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,154.9	$ 16,728.4	$ 59,384.6	$ 54,503.5
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,154.9	$ 16,728.4	$ 59,384.6	$ 54,503.5
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,255.2	$ 8,519.0	$ 29,705.7	$ 27,650.5
Percentage of total net sales and other revenue	51.00%	50.90%	50.00%	50.70%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,762.6	$ 5,583.8	$ 19,588.6	$ 18,675.6
Percentage of total net sales and other revenue	31.70%	33.40%	33.00%	34.30%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,724.4	$ 1,436.7	$ 5,124.2	$ 4,418.7
Percentage of total net sales and other revenue	9.50%	8.60%	8.60%	8.10%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,111.1	$ 906.6	$ 3,968.6	$ 2,874.4
Percentage of total net sales and other revenue	6.10%	5.40%	6.70%	5.30%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 301.6	$ 282.3	$ 997.5	$ 884.3
Percentage of total net sales and other revenue	1.70%	1.70%	1.70%	1.60%